Mirum Pharmaceuticals, Inc.
MIRM
$71.81
$0.290.41%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 14.52% | 12.24% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 14.52% | 12.24% | |||
| Cost of Revenue | 1.75% | 1.04% | |||
| Gross Profit | 17.84% | 15.57% | |||
| SG&A Expenses | 9.67% | 1.54% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.74% | 2.53% | |||
| Operating Income | 67.14% | 37.32% | |||
| Income Before Tax | 60.00% | 43.99% | |||
| Income Tax Expenses | -60.93% | 278.65% | |||
| Earnings from Continuing Operations | 60.07% | 38.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 60.07% | 38.31% | |||
| EBIT | 67.14% | 37.32% | |||
| EBITDA | 111.69% | 49.74% | |||
| EPS Basic | 60.73% | 40.03% | |||
| Normalized Basic EPS | 60.69% | 45.55% | |||
| EPS Diluted | 60.73% | 40.03% | |||
| Normalized Diluted EPS | 60.69% | 45.55% | |||
| Average Basic Shares Outstanding | 1.71% | 2.88% | |||
| Average Diluted Shares Outstanding | 1.71% | 2.88% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||